Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1768163012 | Lanreotide acetate 30mg/vial injection suspension (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 1779490019 | Lanreotide acetate 30mg/vial injection suspension | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 1787155015 | Lanreotide acetate 38mg injection | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lanreotide acetate 30mg/vial injection suspension | Is a | Product containing lanreotide | false | Inferred relationship | Existential restriction modifier | ||
| Lanreotide acetate 30mg/vial injection suspension | Has active ingredient | Lanreotide | false | Inferred relationship | Existential restriction modifier | ||
| Lanreotide acetate 30mg/vial injection suspension | Has active ingredient | Synthetic hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Lanreotide acetate 30mg/vial injection suspension | Has active ingredient | Somatostatin | false | Inferred relationship | Existential restriction modifier | ||
| Lanreotide acetate 30mg/vial injection suspension | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR